Table 3 Analysis of factors associated to HBPM use for monitoring of hypertension (univariate and multivariate analysis)
Univariate | Multivariate | |||||||
|---|---|---|---|---|---|---|---|---|
Never | Occasionally | Regularly | Systematically | OR and 95% CI | p-value | OR and 95% CI | p-value | |
N = 42 | N = 257 | N = 236 | N = 26 | |||||
Sex F, n (%) | 10 (23.8) | 102 (39.7) | 116 (49.2) | 13 (50) | 1.68 [1.22–2.31] | 0.002 | 1.47 [1.04–2.06] | 0.028 |
Age, mean±SD | 53.3±9.9 | 51.8±11.4 | 48.1±11.5 | 50.7±12.1 | 0.98 [0.96–0.9] | < 0.001 | 0.98 [0.97–0.99] | 0.027 |
Urban City> 2500, n (%) | 26 (61.9) | 162 (63) | 150 (63.6) | 14 (53.9) | 0.97 [0.70–1.34] | 0.837 | 0.97 [0.69–1.36] | 0.856 |
GP practice, n (%) | ||||||||
Individual | 24 (57.1) | 102 (39.7) | 74 (31.4) | 10 (38.5) | Ref | Ref | ||
MHC | 15 (35.7) | 138 (53.7) | 129 (54.7) | 14 (53.9) | 1.49 [1.06–2.09] | 0.022 | 1.13 [0.77–1.64] | 0.536 |
Group | 3 (7.1) | 17 (6.6) | 33 (14) | 2 (7.7) | 2.35 [1.33–4.16] | 0.003 | 1.47 [0.80–2.70] | 0.213 |
Clinical Tutor, n (%) | 4 (9.5) | 59 (23) | 82 (34.8) | 8 (30.8) | 1.95 [1.37–2.78] | < 0.001 | 1.90 [1.31–2.75] | 0.001 |